Leaflet INVIRASE 500mg film-coated tablets

Product code:
W42514001
Quantity:
120
Indicated for:
HIV-1 infection
Route of administration:
oral
Substance:
saquinavir (protease inhibitor)
ATC
J05AE01 — Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors

Precautions:

Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning

Use during pregnancy only on medical advice.

Saquinavir is a protease inhibitor used in the treatment of human immunodeficiency virus (HIV) infection. It works by inhibiting the HIV protease enzyme, which is essential for processing viral proteins and forming mature viral particles, thereby reducing viral replication in the body.

Saquinavir is administered orally, usually in combination with other antiretroviral medications, as part of highly active antiretroviral therapy (HAART). It is used to reduce viral load, increase CD4 cell counts, and prevent the progression of the disease to acquired immunodeficiency syndrome (AIDS).

Common side effects include nausea, diarrhea, abdominal pain, and fatigue. In rare cases, severe adverse reactions such as hepatotoxicity, hyperglycemia, or allergic reactions may occur. Regular monitoring of liver function and metabolic parameters is essential.

Saquinavir is an important component of antiretroviral therapy, contributing to the effective management of HIV infection and improving patients' quality of life.

General data about INVIRASE 500mg

Substance:
saquinavir
Date of latest medicines list:
01-06-2016
Product code:
W42514001
Concentration:
500mg
Pharmaceutical form:
film-coated tablets
Quantity:
120
Product type:
Original
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Pharmaceutical forms available for saquinavir

Concentrations available for saquinavir

  • 200mg
  • 500mg